Abstract: A movable close-out shroud suitably configured to substantially cover, partially block, or otherwise close out an articulating opening to a cavity, void, etc., of a first part, such as a passenger seat section. The close-out shroud is configured to move between a stored position and a close-out position.

Abstract: A movable close-out shroud suitably configured to substantially cover, partially block, or otherwise close out an articulating opening to a cavity, void, etc., of a first part, such as a passenger seat section. The close-out shroud is configured to move between a stored position and a close-out position.

Abstract: Described are supports for holding a portable electronic device. The support includes a body having an upper pivot location and a lower pivot location relative to a passenger seat back, a support structure coupled to the body, and a plurality of projections extending from a surface of the support structure. Each projection is shaped to receive a lower edge of a portable electronic device and secure the portable electronic device to the body when the portable electronic device is received by the plurality of projections.

Abstract: The method of fermentation with selected strains of B. trispora described in the present invention makes it possible to achieve lycopene yields higher than those currently described. The methods of isolation, purification and formulation are applicable to any natural source of lycopene, especially to submerged cultures of mucoral fungi of the genera Blakeslea, Choanephora, Phycomyces or Mucor. The method of extraction makes it possible to simplify the recovery process and increase the purity of the product, relative to the methods previously described. The methods of formulation provide high added value, since they make it possible to obtain stabilized preparations of lycopene for direct application in the food and pharmaceutical fields.

Abstract: The present invention describes a method of preparation of formulations of microcrystalline lutein, particularly in the form of esters, which are resistant to oxidation and are soluble in hydrophilic and/or lipophilic media. For these formulations, the esters of lutein are mixed with antioxidants, vegetable oils and/or organic solvents, and this initial mixture is submitted to various stages depending on the type of final formulation required. These formulations are suitable for direct application as colourants in the pharmaceutical, food and cosmetics fields. They can also be used as diet supplements.

Abstract: Process for purifying 7-substituted aminodeacetoxycephalosporins through the use of filter membranes. A process for purification by ultrafiltration and/or nanofiltration with a cut-off for molecular weights over 10,000 Dalton and preferably over 2000 Dalton is described. For example cephalosporin-G of increased purity, represented by a 6-8% increase in the HPLC titre, with a reduction of 50% in absorbance, is obtained using this technique. The invention makes it possible for the purified products to be used directly in the synthesis of other antibiotic compounds without the need for intermediate isolation.